Profile photo Joel van Roon

Joel van Roon

Associate Professor

Strategic program(s):

Recent publications

Proteomic Signatures Over Age Reveal Significant Changes From Infancy Till Late Adulthood Eveline M Delemarre, Hidde M Smits, Debbie van Baarle, Marlies A van Houten, Fiona R M van der Klis, Helen L Leavis, Joel A G van Roon, Lilly M Verhagen, Joanne G Wildenbeest, Femke van Wijk, Julia Drylewicz, Stefan Nierkens
Advanced Biology, 2026, vol. 10
Proteins linked to type II interferon response in Sjögren’s disease Wing Yi Wong, Helen L. Leavis, Sofie L.M. Blokland, Valentin M.D. Baloche, Joel A.G. van Roon
Frontiers in Immunology, 2025, vol. 16
Lidocaine-induced tear production in primary Sjögren's disease Dewi Rijnenberg, Eefje H M van der Heijden, Ronald L A W Bleys, Helen L Leavis, Joël A G van Roon
Annals of the rheumatic diseases, 2025, vol. 84, p.2144-2146
Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease Dewi Rijnenberg, Safae Hamkour, Frank Redegeld, Helen Leavis, Joël van Roon
The Lancet. Rheumatology, 2025, vol. 7, p.e754-e756
CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren’s Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells Anneline C. Hinrichs, Aike A. Kruize, Floris P.J.G. Lafeber, Helen L. Leavis, Joel A.G. van Roon
International Journal of Molecular Sciences, 2023, vol. 24
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response Safae Hamkour, Eefje Hm van der Heijden, Ana P Lopes, Sofie L M Blokland, Cornelis P J Bekker, Cornelia G Van Helden-Meeuwsen, Marjan A Versnel, Aike A Kruize, Timothy Rdj Radstake, Helen L Leavis, Maarten R Hillen, Joel Ag van Roon
RMD Open, 2023, vol. 9